Howard, D., James, D., Parra, J. G., Castillo, B. P., Worthington, J., Williams, N., . . . Gonzalez, D. (2022). Dinaciclib as an effective pan-cyclin dependent kinase inhibitor in platinum resistant ovarian cancer. Frontiers in Oncology, 12, . doi:10.3389/fonc.2022.1014280
Chicago Style CitationHoward, David, et al. "Dinaciclib As an Effective Pan-cyclin Dependent Kinase Inhibitor in Platinum Resistant Ovarian Cancer." Frontiers in Oncology 12 (2022).
MLA CitationHoward, David, et al. "Dinaciclib As an Effective Pan-cyclin Dependent Kinase Inhibitor in Platinum Resistant Ovarian Cancer." Frontiers in Oncology 12 (2022).
Warning: These citations may not always be 100% accurate.